You are now leaving this website.
Are you sure?
NO
YES
  1. CORPORATE - 18-02-2020

    Kedrion Biopharma Announces Completion of Enrollment for CARES10

    A Phase 3, Multi-Center Study to Assess a 10% Ig in Adults with Primary Immunodeficiency Disease

    read more 
  2. CORPORATE - 06-11-2018

    Anti-D 50th Anniversary Celebration Held on Nov. 1, 2018:

    1st Annual International Meeting for Global Eradication of Rh Disease

    read more 

Pages

For more information please contact: pressoffice@kedrion.com